A dominant function of LynB kinase in preventing autoimmunity.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 35452291.
- Also identified by DOI 10.1126/sciadv.abj5227 and PMC identifier 9032976.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Here, we report that the LynB splice variant of the Src-family kinase Lyn exerts a dominant immunosuppressive function in vivo, whereas the LynA isoform is uniquely required to restrain autoimmunity in female mice. We used CRISPR-Cas9 gene editing to constrain <i>lyn</i> splicing and expression, generating single-isoform LynA knockout (LynA<sup>KO</sup>) or LynB<sup>KO</sup> mice. Autoimmune disease in total Lyn<sup>KO</sup> mice is characterized by production of antinuclear antibodies, glomerulonephritis, impaired B cell development, and overabundance of activated B cells and proinflammatory myeloid cells. Expression of LynA or LynB alone uncoupled the developmental phenotype from the autoimmune disease: B cell transitional populations were restored, but myeloid cells and differentiated B cells were dysregulated. These changes were isoform-specific, sexually dimorphic, and distinct from the complete Lyn<sup>KO</sup>. Despite the apparent differences in disease etiology and penetrance, loss of either LynA or LynB had the potential to induce severe autoimmune disease with parallels to human systemic lupus erythematosus (SLE).